Plasma metalloproteinase-9 and restrictive filling pattern as major predictors of outcome in patients with ischemic cardiomyopathy

Cohn, 2000, Cardiac remodeling: concepts and clinical implications, J Am Coll Cardiol, 35, 569, 10.1016/S0735-1097(99)00630-0 Spinale, 1999, Matrix metalloproteinase inhibition during the development of congestive heart failure. Effects on left ventricular dimensions and function, Cir Res, 85, 364, 10.1161/01.RES.85.4.364 Yun, 2000, Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling, Cardiovasc Res, 46, 214, 10.1016/S0008-6363(00)00003-1 Tziakas, 2005, Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy, Am J Cardiol, 96, 1449, 10.1016/j.amjcard.2005.06.096 Ohtsuka, 2007, Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy, J Card Fail, 13, 752, 10.1016/j.cardfail.2007.06.730 Squire, 2004, Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohormonal parameters of left ventricular dysfunction, J Card Fail, 10, 328, 10.1016/j.cardfail.2003.11.003 Wagner, 2006, Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction, J Card Fail, 12, 66, 10.1016/j.cardfail.2005.08.002 Kelly, 2007, Plasma matrix metalloproteinase-9 and left ventricular remodeling after acute myocardial infarction in man, Eur Heart J, 28, 711, 10.1093/eurheartj/ehm003 Kelly, 2008, Plasma tissue inhibitors of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodeling and prognosis after acute myocardial infarction, Eur Heart J, 29, 2116, 10.1093/eurheartj/ehn315 Cerisano, 1999, Doppler-derived mitral deceleration time: an early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction, Circulation, 99, 230, 10.1161/01.CIR.99.2.230 Temporelli, 2004, Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy, J Am Coll Cardiol, 43, 1646, 10.1016/j.jacc.2003.12.036 Lang, 2005, J Am Soc Echocardiogr, 18, 1440, 10.1016/j.echo.2005.10.005 Nagueh, 2009, Recommendations for the evaluation of left ventricular diastolic function by echocardiography, J Am Soc Echocardiogr, 22, 107, 10.1016/j.echo.2008.11.023 Damy, 2010, Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure, Eur Heart J, 31, 2280, 10.1093/eurheartj/ehq245 Grayburn, 2003, Recommendations for evaluation of the severity of native valvular regurgiation with two-dimensional and Doppler echocardiography, J Am Soc Echocardiogr, 16, 777, 10.1016/S0894-7317(03)00335-3 Kircher, 1990, Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava, Am J Cardiol, 66, 493, 10.1016/0002-9149(90)90711-9 Smilde, 2006, Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction, Circulation, 114, 1572, 10.1161/CIRCULATIONAHA.105.610642 Cluetjens, 1995, Collagen remodeling after myocardial infarction in the rat heart, Am J Pathol, 147, 325 Pencina, 2008, Evaluating the added predictive ability of a new marker: from the area under the ROC curve to the reclassification and beyond, Stat Med, 27, 157, 10.1002/sim.2929 Weber, 1991, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system, Circulation, 83, 1849, 10.1161/01.CIR.83.6.1849 Woessner, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodeling, FASEB J, 5, 2145, 10.1096/fasebj.5.8.1850705 Sundstrom, 2004, Relations of matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study, Circulation, 109, 2850, 10.1161/01.CIR.0000129318.79570.84 Orn, 2007, Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function, J Card Fail, 13, 843, 10.1016/j.cardfail.2007.07.006 Frantz, 2008, Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality, Eur J Heart Fail, 10, 388, 10.1016/j.ejheart.2008.02.015 George, 2005, Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure, Am Heart J, 150, 484, 10.1016/j.ahj.2004.11.016 Nijland, 1997, Prognostic implications of restrictive left ventricular filling in acute myocardial infarction, J Am Coll Cardiol, 30, 1618, 10.1016/S0735-1097(97)00369-0 Poulsen, 1999, Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction, Am Heart J, 137, 910, 10.1016/S0002-8703(99)70416-3 Giannuzzi, 1996, Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction, J Am Coll Cardiol, 28, 383, 10.1016/0735-1097(96)00163-5 2008, Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators. Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis, Eur J Heart Fail, 10, 786, 10.1016/j.ejheart.2008.06.005 Yong, 2001, Deceleration time in ischemic cardiomyopathy: relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization, Circulation, 103, 1232, 10.1161/01.CIR.103.9.1232 Pozzoli, 1997, Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure, Circulation, 95, 1222, 10.1161/01.CIR.95.5.1222 Vorovich, 2008, Comparison of matrix metalloproteinase-9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure, Am Heart J, 155, 992, 10.1016/j.ahj.2008.01.007 Iraqi, 2009, Circulation, 119, 2471, 10.1161/CIRCULATIONAHA.108.809194 Carluccio, 2009, Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy, Eur Heart J, 30, 1501, 10.1093/eurheartj/ehp125